Jump to content

Osimertinib Tri-Challenge


Judy M2

Recommended Posts

9 minutes ago, Judy M2 said:

In this study, a patient had progession on first-line osimertinib (Tagrisso), had chemo, re-challenged osimertinib, had more progression and more chemo and again re-challenged osimertinib with good results. 

https://www.wjgnet.com/2307-8960/full/v9/i11/2627.htm

Thanks so much for sharing this important information!  Wishing you a great day!  Susan 

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.